Amy Bachyrycz1,2, Shikhar Shrestha1, Barry E Bleske1, Dale Tinker3, Ludmila N Bakhireva1,4,5. 1. a Department of Pharmacy Practice and Administrative Sciences , College of Pharmacy, University of New Mexico , Albuquerque , New Mexico , USA. 2. b Walgreens Pharmacy , Albuquerque , New Mexico , USA. 3. c New Mexico Pharmacists Association , New Mexico , USA. 4. d Department of Family and Community Medicine , School of Medicine, University of New Mexico , Albuquerque , New Mexico , USA. 5. e Division of Epidemiology and Biostatistics, Department of Internal Medicine , School of Medicine, University of New Mexico , Albuquerque , New Mexico , USA.
Abstract
BACKGROUND: Given that opioid misuse/abuse and opioid overdose have reached epidemic proportions in the United States, expansion of naloxone access programs are desperately needed. The objective of this study was to describe emerging trends in naloxone rescue kit (NRK) prescription patterns by pharmacists in New Mexico as an example of a unique health care delivery system. METHODS: The study presents cross-sectional analysis of the data on NRK prescriptions by pharmacists who received naloxone pharmacist prescriptive authority certification since 2013. Data were obtained from the Prevention of Opioid Overdose by New Mexico Pharmacists (POINt-Rx) Registry, maintained by the University of New Mexico and the New Mexico Pharmacists Association. RESULTS: Since 2013, 133 NRKs prescribed by pharmacists have been reported to the POINt-Rx Registry. The mean age of the patients was 41.5 ± 12.0 years (range: 19-67 years), and 60.2% were female participants. Only 11.3% of the prescriptions were from pharmacists practicing in rural/mixed urban-rural areas. The majority of NRKs (89.5%) were first-time prescriptions. The most common reason for a NRK prescription was patient's request (56.4%), followed by a pharmacist's prescription of NRK due to high dose of prescription opioids (28.6%) and history of opioid misuse/abuse (15.0%). In addition to opioids, other frequently reported substances included alcohol (9.2%) and benzodiazepines (10.8%). More than a third of patients (38.5%) reported polysubstance use in the previous 72 hours. CONCLUSIONS: These results indicate that patients at risk of opioid overdose might feel comfortable soliciting NRKs from a pharmacist. Participation of pharmacists in rural areas in the naloxone prescriptive authority highlight the opportunity for this novel health care delivery model in underserved areas; however, the program is clearly underutilized in these areas. Such a model can provide expanded patient access in community practices, whereas systematic efforts for uptake of the program by policy makers, communities, and pharmacists continue to be needed nationwide.
BACKGROUND: Given that opioid misuse/abuse and opioid overdose have reached epidemic proportions in the United States, expansion of naloxone access programs are desperately needed. The objective of this study was to describe emerging trends in naloxone rescue kit (NRK) prescription patterns by pharmacists in New Mexico as an example of a unique health care delivery system. METHODS: The study presents cross-sectional analysis of the data on NRK prescriptions by pharmacists who received naloxone pharmacist prescriptive authority certification since 2013. Data were obtained from the Prevention of Opioid Overdose by New Mexico Pharmacists (POINt-Rx) Registry, maintained by the University of New Mexico and the New Mexico Pharmacists Association. RESULTS: Since 2013, 133 NRKs prescribed by pharmacists have been reported to the POINt-Rx Registry. The mean age of the patients was 41.5 ± 12.0 years (range: 19-67 years), and 60.2% were female participants. Only 11.3% of the prescriptions were from pharmacists practicing in rural/mixed urban-rural areas. The majority of NRKs (89.5%) were first-time prescriptions. The most common reason for a NRK prescription was patient's request (56.4%), followed by a pharmacist's prescription of NRK due to high dose of prescription opioids (28.6%) and history of opioid misuse/abuse (15.0%). In addition to opioids, other frequently reported substances included alcohol (9.2%) and benzodiazepines (10.8%). More than a third of patients (38.5%) reported polysubstance use in the previous 72 hours. CONCLUSIONS: These results indicate that patients at risk of opioid overdose might feel comfortable soliciting NRKs from a pharmacist. Participation of pharmacists in rural areas in the naloxone prescriptive authority highlight the opportunity for this novel health care delivery model in underserved areas; however, the program is clearly underutilized in these areas. Such a model can provide expanded patient access in community practices, whereas systematic efforts for uptake of the program by policy makers, communities, and pharmacists continue to be needed nationwide.
Entities:
Keywords:
Community pharmacy; delivery of health care; naloxone; opioids
Authors: Erik D Barton; Christopher B Colwell; Timothy Wolfe; Dave Fosnocht; Craig Gravitz; Tamara Bryan; Will Dunn; Jeff Benson; Jeff Bailey Journal: J Emerg Med Date: 2005-10 Impact factor: 1.484
Authors: Su Albert; Fred W Brason; Catherine K Sanford; Nabarun Dasgupta; Jim Graham; Beth Lovette Journal: Pain Med Date: 2011-06 Impact factor: 3.750
Authors: Nickolas D Zaller; Michael A Yokell; Traci Craig Green; Julia Gaggin; Patricia Case Journal: Subst Use Misuse Date: 2013-06-10 Impact factor: 2.164
Authors: Theodore M Hammett; Son Phan; Julia Gaggin; Patricia Case; Nicholas Zaller; Alexandra Lutnick; Alex H Kral; Ekaterina V Fedorova; Robert Heimer; Will Small; Robin Pollini; Leo Beletsky; Carl Latkin; Don C Des Jarlais Journal: BMC Health Serv Res Date: 2014-06-17 Impact factor: 2.655
Authors: Minji Sohn; Jeffery C Talbert; Chris Delcher; Emily R Hankosky; Michelle R Lofwall; Patricia R Freeman Journal: Health Serv Res Date: 2020-02-07 Impact factor: 3.402
Authors: Benjamin Levy; Bridget Spelke; Leonard J Paulozzi; Jeneita M Bell; Kurt B Nolte; Sarah Lathrop; David E Sugerman; Michael Landen Journal: Drug Alcohol Depend Date: 2016-08-03 Impact factor: 4.492
Authors: Antoinette L Spector; Carol L Galletly; Erika A Christenson; H Danielle Green Montaque; Julia Dickson-Gomez Journal: BMC Public Health Date: 2022-07-19 Impact factor: 4.135